- Featured Product
- KD/KO Validated
CSNK2B-specific Polyclonal antibody
CSNK2B-specific Polyclonal Antibody for FC, IHC, WB, ELISA
Cat no : 20234-1-AP
Validation Data Gallery
|Positive WB detected in||HepG2 cells, MCF-7 cells, A431 cells, HeLa cells|
|Positive IHC detected in||human breast cancer tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive FC detected in||HeLa cells|
|Western Blot (WB)||WB : 1:500-1:3000|
|Immunohistochemistry (IHC)||IHC : 1:50-1:500|
|Sample-dependent, check data in validation data gallery|
20234-1-AP targets CSNK2B-specific in WB, IHC, IF, FC, ELISA applications and shows reactivity with human samples.
|Cited Reactivity||human, mouse|
|Host / Isotype||Rabbit / IgG|
|Full Name||casein kinase 2, beta polypeptide|
|Calculated molecular weight||25 kDa|
|Observed molecular weight||25 kDa|
|GenBank accession number||NM_001320|
|Gene ID (NCBI)||1460|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
CSNK2B, also named as CK2N, G5A nd CK II beta, belongs to the casein kinase 2 subunit beta family. CSNK2B participates in Wnt signaling. It plays a complex role in regulating the basal catalytic activity of the alpha subunit. The antibody is specific to CSNK2B.
Redox-sensitive activation of CCL7 by BRG1 in hepatocytes during liver injury.
Spiropachysine A suppresses hepatocellular carcinoma proliferation by inducing methuosis in vitro and in vivo.
Front Mol Neurosci
Lovastatin Alleviates α-Synuclein Aggregation and Phosphorylation in Cellular Models of Synucleinopathy.
J Cell Commun Signal
CSNK2B contributes to colorectal cancer cell proliferation by activating the mTOR signaling.
Exp Cell Res
Oocyte-specific deletion of Gsα induces oxidative stress and deteriorates oocyte quality in mice.
J Exp Clin Cancer Res
Overexpression of NELFE contributes to gastric cancer progression via Wnt/β-catenin signaling-mediated activation of CSNK2B expression.